Stock information

Stock information   

VALBIOTIS specializes in developing innovative nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. Its products are made for manufacturers in the agro-food and pharmaceutical industries. VALBIOTIS particularly focuses on solutions to prevent type 2 diabetes, NASH (nonalcoholic steatohepatitis), obesity and cardiovascular diseases.
Valbiotis has been listed on Euronext Growth since 7 June 2017.

  • Label: Valbiotis
  • Mnemonic: ALVAL
  • ISIN Code: FR 0013254851
  • PEA PME eligible: Oui
  • Trading Market:
    • ALTERNEXT ALLSHARE
    • NEXT BIOTECH
  • Total number of shares: 3 647 072

Capital allocation

  • Institution: Portzamparc
  • Analyst: Christophe Dombu
  • Institution: Invest Securities
  • Analysts: Martial Descoutures – Thibaut Voglimacci-Stephanopoli